Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing–remitting multiple sclerosis

References

• Van der Walt A, Butzkueven H, Kolbe S, Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade. Pharmacol Ther 2010;126(1):82–93.
   PubMedGoogle Scholar
• Gonsette R. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 2008;274(1):48–53.
   PubMedGoogle Scholar
• Pennisi G, Cornelius C, Cavallaro M, et al. Redox regulation of cellular stress response in multiple sclerosis. Biochem Pharmacol 2011;82(10):1490–9.
   PubMedGoogle Scholar
• Miller E, Walczak A, Saluk J, Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem 2011;45(1–2):26–30.
   PubMedGoogle Scholar
• Tasset I, Agüera E, Sánchez-López F, et al. Peripheral oxidative stress in relapsing–remitting multiple sclerosis. Clin Biochem 2012;45(6):440–444.
   PubMed Web of Science ®Google Scholar
• Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complement Ther Med 2011;19(4):228–37.
   PubMed Web of Science ®Google Scholar
• Adamczyk-Sowa M, Sowa P, Pierzchala K, Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients. J Physiol Pharmacol 2012;63(6):683–90.
   PubMed Web of Science ®Google Scholar
• Schreibelt G, van Horssen J, van Rossum S, Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 2007;56(2):322–30.
   PubMedGoogle Scholar
• Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood–brain barrier in multiple sclerosis? FEBS Lett 2011;585(23):3770–80.
   PubMed Web of Science ®Google Scholar
• Montero R, Pineda M, Aracil A, et al. Clinical, biochemical and molecular aspects of cerebellar ataxia and coenzyme Q10 deficiency. Cerebellum 2007;6(2):118–22.
   PubMedGoogle Scholar
• Moreira PI, Santos MS, Sena C, CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol 2005;196(1):112–9.
   PubMedGoogle Scholar
• Ishrat T, Khan MB, Hoda MN, et al. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 2006;171(1):9–16.
   PubMed Web of Science ®Google Scholar
• Groneberg DA, Kindermann B, Althammer M, et al. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 2005;37(6):1208–18.
   PubMed Web of Science ®Google Scholar
• Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (ubiquinone). Regul Toxicol Pharmacol 2006;45(3):282–8.
   PubMedGoogle Scholar
• Mancuso M, Orsucci D, Calsolaro V, Coenzyme Q10 and neurological diseases. Pharmaceuticals 2009;2(3):134–49.
   Google Scholar
• Yang X, Yang Y, Li G, Coenzyme Q10 attenuates β-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation. J Mol Neurosci 2008;34(2):165–71.
   PubMed Web of Science ®Google Scholar
• Yang L, Calingasan NY, Wille EJ, Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. J Neurochem 2009;109(5):1427–39.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50(1):121–7.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis results of an international survey. Neurology 1996;46(4):907–11.
   PubMed Web of Science ®Google Scholar
• van Horssen J, Witte ME, Schreibelt G, de Vries HE. Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta Mol Basis Dis. 2011;1812(2):141–50.
   PubMed Web of Science ®Google Scholar
• Lee BJ, Lin YC, Huang YC, The relationship between coenzyme Q10, oxidative stress, and antioxidant enzymes activities and coronary artery disease. Sci World J 2012;2012:1–8.
   Google Scholar
• Tiano L, Belardinelli R, Carnevali P, Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007;28(18):2249–55.
   PubMed Web of Science ®Google Scholar
• Tsai KL, Huang YH, Kao CL, et al. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem 2012;23(5):458–68.
   PubMed Web of Science ®Google Scholar
• Tawfik MK. Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stress. Epilepsy Behav 2011;22(4):671–677.
   PubMedGoogle Scholar
• Fouad AA, Al-Sultan AI, Refaie SM, Yacoubi MT. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicol 2010;274(1):49–56.
   PubMed Web of Science ®Google Scholar
• Choi BS, Song HS, Kim HR, Effect of coenzyme Q10 on cutaneous healing in skin-incised mice. Arch Pharm Res 2009;32(6):907–13.
   PubMedGoogle Scholar
• Ghule AE, Kulkarni CP, Bodhankar SL, Pandit VA. Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats. Curr Ther Res 2009;70(6):460–71.
   PubMedGoogle Scholar
• Modi K, Santani D, Goyal R, Bhatt P. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats. Biol Trace Elem Res 2006;109(1):25–33.
   PubMed Web of Science ®Google Scholar
• Kędziora-Kornatowska K, Czuczejko J, Motyl J, Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A Pilot Study Arch Med Sci 2010;6:513–8.
   PubMedGoogle Scholar
• Lass A, Sohal RS. Effect of coenzyme Q(10) and alpha-tocopherol content of mitochondria on the production of superoxide anion radicals. FASEB J 2000;14(1):87–94.
   PubMed Web of Science ®Google Scholar
• Kopff M, Zakrzewska I, Czernicki J, Red cell superoxide dismutase and catalase activity in multiple sclerosis. Acta Biochim Pol 1993;40(1):154.
   PubMedGoogle Scholar
• Besler HİT, Çomoğlu SÇ, OkÇu Zİ. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 2002;5(3):215–20.
   PubMed Web of Science ®Google Scholar
• Długosz A, Kuźniar J, Sawicka E, Oxidative stress and coenzyme Q10 supplementation in renal transplant recipients. Int Urol Nephrol 2004;36(2):253–8.
   PubMedGoogle Scholar
• Kwong LK, Kamzalov S, Rebrin I, Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 2002;33(5):627–38.
   PubMed Web of Science ®Google Scholar
• Wagner AE, Ernst IM, Birringer M, A combination of lipoic acid plus coenzyme Q10 induces PGC1alpha, a master switch of energy metabolism, improves stress response, and increases cellular glutathione levels in cultured C2C12 skeletal muscle cells. Oxid Med Cell Longev 2012;2012:835970.
   PubMedGoogle Scholar
• Yamada K. Changes in antioxidants and lipid peroxides during ischemia in the rat brain. Pathophysiology 1994;1(2):105–12.
   Google Scholar
• Keles M, Taysi S, Aksoy H, Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis. Can J Neurol Sci 2001;28(2):141–3.
   PubMed Web of Science ®Google Scholar
• Haider L, Fischer MT, Frischer JM, Oxidative damage in multiple sclerosis lesions. Brain 2011;134(7):1914–24.
   PubMedGoogle Scholar
• Naidoo R, Knapp ML. Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clin Chem 1992;38(12):2449–54.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15(4):316–28.
   PubMed Web of Science ®Google Scholar
• Barbara T, Anna Paola B, Angela Maria A, Serum metabolic profile in multiple sclerosis patients. Mult Scler Int 2011;2011:1–8.
   Google Scholar
• Miller E, Mrowicka M, Saluk-Juszczak J, Ireneusz M. The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis. Neurochem Res 2011;36(6):1012–6.
   PubMed Web of Science ®Google Scholar
• Özdoğan S, Kaman D, Şimşek BÇ. Effects of coenzyme Q10 and α-lipoic acid supplementation in fructose fed rats. J Clin Biochem Nutr 2012;50(2):145.
   PubMedGoogle Scholar
• Singh RB, Shinde SN, Chopra RK, Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis 2000;148(2):275.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Del Rio D, Zini A, Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease. Neurosci Lett 2006;401(3):203–8.
   PubMedGoogle Scholar
• Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998;44(6):1309–15.
   PubMed Web of Science ®Google Scholar
• Niki E. Assessment of antioxidant capacity in vitro and in vivo. Free Radic Biol Med 2010;49(4):503–15.
   PubMed Web of Science ®Google Scholar
• Oliveira SR, Kallaur AP, Morimoto HK, Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale. J Neurol Sci 2012;321(1–2):49–53.
   PubMed Web of Science ®Google Scholar
• Acar A, Ugur Cevik M, Evliyaoglu O, Evaluation of serum oxidant/antioxidant balance in multiple sclerosis. Acta Neurol Belg 2012;112(3):275–280.
   PubMed Web of Science ®Google Scholar
• Besler HT, Çomogˇlu S. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci 2003;6(3): 189–96.
   PubMed Web of Science ®Google Scholar
• Díaz-Castro J, Guisado R, Kajarabille N, Coenzyme Q10 supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise. Eur J Nutr 2011;51(7):791–799.
   PubMedGoogle Scholar
• Mancini A, Milardi D, Meucci E, , eds. Coenzyme Q10 effects on non-enzymatic total antioxidant capacity in seminal plasma of varicocele patients. International Congress Series 2004;1271:215–218.
   Google Scholar
• Watts G, Playford D, Croft K, Coenzyme Q10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus. Diabetologia 2002;45(3):420–6.
   PubMedGoogle Scholar
• Sakata T, Furuya R, Shimazu T, Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients. Blood Purif 2008;26(4):371–8.
   PubMedGoogle Scholar
• Koch M, Mostert J, Arutjunyan A, Plasma lipid peroxidation and progression of disability in multiple sclerosis. Eur J Neurol 2007;14(5):529–33.
   PubMed Web of Science ®Google Scholar
• Shults CW, Oakes D, Kieburtz K, Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002;59(10):1541.
   PubMed Web of Science ®Google Scholar